Free Trial

Kymera Therapeutics (KYMR) Short Interest Ratio & Short Volume

Kymera Therapeutics logo
$35.88 +1.33 (+3.84%)
As of 10:46 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Kymera Therapeutics Short Interest Data

Kymera Therapeutics (KYMR) has a short interest of 7.37 million shares, representing 13.52% of the float (the number of shares available for trading by the public). This marks a -7.76% decrease in short interest from the previous month. The short interest ratio (days to cover) is 10.5, indicating that it would take 10.5 days of the average trading volume of 554,096 shares to cover all short positions.

Current Short Interest
7,370,000 shares
Previous Short Interest
7,990,000 shares
Change Vs. Previous Month
-7.76%
Dollar Volume Sold Short
$187.64 million
Short Interest Ratio
10.5 Days to Cover
Last Record Date
April 15, 2025
Outstanding Shares
64,944,000 shares
Short Percent of Float
13.52%
Today's Trading Volume
87,544 shares
Average Trading Volume
554,096 shares
Today's Volume Vs. Average
16%
Short Selling Kymera Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Kymera Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

KYMR Short Interest Over Time

KYMR Days to Cover Over Time

KYMR Percentage of Float Shorted Over Time

Kymera Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/20257,370,000 shares $187.64 million -7.8%13.5%10.5 $25.46
3/31/20257,990,000 shares $218.69 million +1.9%14.7%12.2 $27.37
3/15/20257,840,000 shares $269.46 million +3.4%14.4%13.5 $34.37
2/28/20257,580,000 shares $237.63 million +3.3%13.9%13.6 $31.35
2/15/20257,340,000 shares $270.70 million -4.6%13.5%15 $36.88
1/31/20257,690,000 shares $304.45 million -7.9%N/A16 $39.59
1/15/20258,350,000 shares $363.73 million -4.8%N/A17.5 $43.56
12/31/20248,770,000 shares $352.82 million -0.2%N/A20.2 $40.23
12/15/20248,790,000 shares $370.32 million -2.6%N/A20.2 $42.13
11/30/20249,020,000 shares $422.59 million -1.1%N/A20.8 $46.85
11/15/20249,120,000 shares $382.68 million -0.4%N/A21.9 $41.96
10/31/20249,160,000 shares $422.92 million +1.0%N/A22.2 $46.17
10/15/20249,070,000 shares $406.34 million +3.0%N/A21.4 $44.80
9/30/20248,810,000 shares $416.98 million -7.2%N/A17.5 $47.33
9/15/20249,490,000 shares $437.30 million +1.5%N/A16.8 $46.08
8/31/20249,350,000 shares $452.17 million -1.3%N/A16.2 $48.36
8/15/20249,470,000 shares $417.06 million -3.9%N/A15.6 $44.04
7/31/20249,850,000 shares $455.07 million -0.2%N/A16.1 $46.20
7/15/20249,870,000 shares $444.15 million +5.2%N/A16.1 $45.00
6/30/20249,380,000 shares $279.99 million -7.5%N/A16.4 $29.85
6/15/202410,140,000 shares $337.56 million +1.5%N/A19.6 $33.29
5/31/20249,990,000 shares $320.78 million +1.2%N/A17.6 $32.11
5/15/20249,870,000 shares $354.73 million -0.4%N/A16.9 $35.94
4/30/20249,910,000 shares $333.17 million +2.2%N/A16.2 $33.62
4/15/20249,700,000 shares $333.58 million +7.1%N/A14.8 $34.39
3/31/20249,060,000 shares $364.21 million +8.8%N/A12 $40.20
3/15/20248,330,000 shares $338.03 million +1.0%N/A10.2 $40.58
2/29/20248,250,000 shares $352.28 million -1.8%N/A9 $42.70
2/15/20248,400,000 shares $314.33 million +1.7%N/A9.4 $37.42
1/31/20248,260,000 shares $270.76 million -4.2%N/A8.9 $32.78
1/15/20248,620,000 shares $242.39 million -4.9%N/A9.3 $28.12
12/31/20239,060,000 shares $230.67 million +4.4%N/A9.4 $25.46
12/15/20238,680,000 shares $226.37 million +12.9%N/A9.9 $26.08
11/30/20237,690,000 shares $159.64 million +3.2%N/A10.3 $20.76
11/15/20237,450,000 shares $134.77 million -8.0%N/A11.2 $18.09
10/31/20238,100,000 shares $94.53 million +10.7%N/A13.9 $11.67
10/15/20237,320,000 shares $92.31 million +0.4%N/A14.2 $12.61
9/30/20237,290,000 shares $101.33 million -1.8%N/A17.9 $13.90
9/15/20237,420,000 shares $141.35 million +3.6%N/A19.7 $19.05
8/31/20237,160,000 shares $136.61 million -2.3%N/A17.1 $19.08
Trump to solve American wealth loss? (Ad)

Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.

If you missed out on a bitcoin fortune, this could be your second chance. A brief “wealth window” is
8/15/20237,330,000 shares $143.74 million -3.9%N/A15.5 $19.61
7/31/20237,630,000 shares $166.94 million -5.5%N/A15.3 $21.88
7/15/20238,070,000 shares $178.67 million -0.6%N/A15.5 $22.14
6/30/20238,120,000 shares $186.68 million -2.3%N/A15.2 $22.99
6/15/20238,310,000 shares $229.94 million -10.1%N/A15.5 $27.67
5/31/20239,240,000 shares $272.03 million -2.0%N/A18.8 $29.44
5/15/20239,430,000 shares $281.96 million -2.0%21.3%20.8 $29.90
4/30/20239,620,000 shares $303.41 million -0.2%21.7%21.4 $31.54
4/15/20239,640,000 shares $316.77 million +0.5%21.8%21.4 $32.86
3/31/20239,590,000 shares $284.15 million +2.0%21.7%18.6 $29.63
3/15/20239,400,000 shares $292.62 million -0.6%21.3%17.6 $31.13
2/28/20239,460,000 shares $296.85 million -0.7%21.4%13.2 $31.38
2/15/20239,530,000 shares $314.49 million -1.1%21.7%13.1 $33.00
1/31/20239,640,000 shares $360.34 million +2.4%21.9%12.9 $37.38
1/15/20239,410,000 shares $325.02 million +4.6%21.4%12.3 $34.54
12/30/20229,000,000 shares $224.64 million +11.8%20.5%11.7 $24.96
12/15/20228,050,000 shares $224.60 million +9.8%18.4%10.6 $27.90
11/30/20227,330,000 shares $212.42 million -7.0%16.9%11.7 $28.98
11/15/20227,880,000 shares $236.64 million -5.6%18.1%12.3 $30.03
10/31/20228,350,000 shares $253.34 million +8.4%19.3%12.6 $30.34
10/15/20227,700,000 shares $169.40 million +1.9%18.0%11.6 $22.00
9/30/20227,560,000 shares $164.58 million +10.2%17.9%11.7 $21.77
9/15/20226,860,000 shares $197.29 million +7.7%16.2%9.9 $28.76
8/31/20226,370,000 shares $180.08 million +7.4%15.1%8.9 $28.27
8/15/20225,930,000 shares $200.08 million -3.3%14.8%8.2 $33.74
7/31/20226,130,000 shares $135.04 million -4.1%15.3%8 $22.03
7/15/20226,390,000 shares $148.44 million +10.0%16.0%8 $23.23
6/30/20225,810,000 shares $114.40 million +16.9%14.5%7.5 $19.69
6/15/20224,970,000 shares $70.47 million +1.0%12.4%6.8 $14.18
5/31/20224,920,000 shares $70.21 million -0.2%12.3%7.6 $14.27
5/15/20224,930,000 shares $85.98 million +42.5%12.3%8.4 $17.44
4/30/20223,460,000 shares $108.47 million +6.1%8.7%6.8 $31.35
4/15/20223,260,000 shares $124.01 million +7.6%8.2%8 $38.04
3/31/20223,030,000 shares $128.23 million -3.5%7.6%7.4 $42.32
3/15/20223,140,000 shares $111.97 million +11.4%9.4%8 $35.66
2/28/20222,820,000 shares $112.12 million +8.1%8.4%7.2 $39.76
2/15/20222,610,000 shares $114.14 million +13.5%7.8%6.8 $43.73
1/31/20222,300,000 shares $96.60 million +12.2%7.5%6.4 $42.00
1/15/20222,050,000 shares $84.19 million +3.5%6.0%6.1 $41.07
12/31/20211,980,000 shares $125.71 million +17.2%5.8%7 $63.49
12/15/20211,690,000 shares $93.71 million -0.6%4.9%5.9 $55.45
11/30/20211,700,000 shares $94.38 million +13.3%5.0%5.6 $55.52
11/15/20211,500,000 shares $91.95 million +4.9%4.4%4.9 $61.30
10/29/20211,430,000 shares $84.20 million +0.7%4.4%4.4 $58.88
10/15/20211,420,000 shares $81.22 million -13.9%4.3%4.3 $57.20
9/30/20211,650,000 shares $96.92 million +8.6%5.0%4.5 $58.74
9/15/20211,520,000 shares $98.78 million -10.1%4.6%3.1 $64.99
8/31/20211,690,000 shares $105.02 million -15.5%5.1%3.5 $62.14
8/13/20212,000,000 shares $107.88 million -2.9%6.2%4.2 $53.94
7/30/20212,060,000 shares $123.97 million +5.6%7.1%4.2 $60.18
Trump to solve American wealth loss? (Ad)

Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.

If you missed out on a bitcoin fortune, this could be your second chance. A brief “wealth window” is
7/15/20211,950,000 shares $93.83 million -17.4%6.7%4 $48.12
6/30/20212,360,000 shares $114.46 million +30.4%8.1%4.8 $48.50
6/15/20211,810,000 shares $88.40 million -7.7%6.9%4.7 $48.84
5/28/20211,960,000 shares $94.26 million -8.8%7.4%4.5 $48.09
5/14/20212,150,000 shares $97.55 million -9.3%8.2%5 $45.37
4/30/20212,370,000 shares $108.31 million +3.0%9.6%6 $45.70
4/15/20212,300,000 shares $83.47 million +6.5%9.4%6.4 $36.29
3/31/20212,160,000 shares $78.68 million +100.0%8.9%6.7 $36.43
3/15/20211,080,000 shares $60.59 million +3.9%4.4%3.6 $56.10
2/26/20211,040,000 shares $51.58 million -13.3%4.3%4.9 $49.60
2/12/20211,200,000 shares $82.88 million +0.8%5.2%6.5 $69.07
1/29/20211,190,000 shares $76.01 million +8.2%5.2%6.9 $63.87
1/15/20211,100,000 shares $89.43 million No Change4.8%6.7 $81.30

KYMR Short Interest - Frequently Asked Questions

What is Kymera Therapeutics' current short interest?

Short interest is the volume of Kymera Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 7,370,000 shares of KYMR short. 13.52% of Kymera Therapeutics' shares are currently sold short. Learn More on Kymera Therapeutics' current short interest.

What is a good short interest ratio for Kymera Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KYMR shares currently have a short interest ratio of 10.0. Learn More on Kymera Therapeutics's short interest ratio.

Which institutional investors are shorting Kymera Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Kymera Therapeutics: Group One Trading LLC, Citadel Advisors LLC, Jane Street Group LLC, Susquehanna International Group LLP, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Kymera Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.52% of Kymera Therapeutics' floating shares are currently sold short.

Is Kymera Therapeutics' short interest increasing or decreasing?

Kymera Therapeutics saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 7,370,000 shares, a decrease of 7.8% from the previous total of 7,990,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Kymera Therapeutics' short interest compare to its competitors?

13.52% of Kymera Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Kymera Therapeutics: Roivant Sciences Ltd. (11.68%), Revolution Medicines, Inc. (10.62%), Lantheus Holdings, Inc. (10.23%), BridgeBio Pharma, Inc. (15.57%), TG Therapeutics, Inc. (16.90%), Legend Biotech Co. (5.49%), Sarepta Therapeutics, Inc. (7.51%), ADMA Biologics, Inc. (5.82%), Blueprint Medicines Co. (9.08%), Verona Pharma plc (10.22%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks.

What does it mean to sell short Kymera Therapeutics stock?

Short selling KYMR is an investing strategy that aims to generate trading profit from Kymera Therapeutics as its price is falling. KYMR shares are trading up $0.28 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Kymera Therapeutics?

A short squeeze for Kymera Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KYMR, which in turn drives the price of the stock up even further.

How often is Kymera Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KYMR, twice per month. The most recent reporting period available is April, 15 2025.




This page (NASDAQ:KYMR) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners